Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,252 | 36,136 | 48,044 | 38,731 | 47,319 |
| Marketable Securities | 3,390 | 6,085 | 8,045 | 8,555 | 8,610 |
| Receivables | N/A | N/A | N/A | 22,823 | 908 |
| Inventories | N/A | N/A | N/A | 0 | 105 |
| TOTAL | $32,644 | $43,596 | $56,815 | $71,342 | $58,165 |
| Non-Current Assets | |||||
| PPE Net | 285 | 389 | 507 | 640 | 779 |
| Intangibles | 562 | 713 | 452 | 186 | 201 |
| TOTAL | $847 | $1,102 | $959 | $826 | $980 |
| Total Assets | $33,491 | $44,698 | $57,774 | $72,168 | $59,145 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,796 | 1,100 | 1,707 | 1,214 | 1,462 |
| Accrued Expenses | 6,503 | 7,049 | 7,788 | 10,263 | 5,732 |
| TOTAL | $8,299 | $8,149 | $9,495 | $11,477 | $7,194 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 436 | 488 | 578 | 786 | 262 |
| TOTAL | $436 | $488 | $578 | $786 | $262 |
| Total Liabilities | $8,735 | $8,637 | $10,073 | $12,263 | $7,456 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45 | 45 | 45 | 45 | 45 |
| Common Shares | 63 | 63 | 63 | 63 | 63 |
| Retained earnings | -438,633 | -425,831 | -413,249 | -400,231 | -407,635 |
| TOTAL | $24,756 | $36,061 | $47,701 | $59,905 | $51,689 |
| Total Liabilities And Equity | $33,491 | $44,698 | $57,774 | $72,168 | $59,145 |